Sara Zborovski

Sara Zborovski stands out as a guiding force within the Corporate Group at her firm, leveraging her expertise in regulatory and commercial law to assist businesses under the purview of Health Canada. She skillfully navigates the complex regulatory frameworks of the Food and Drugs Act, the Cannabis Act, among others, ensuring her clients in the pharmaceutical, cannabis, food and beverage, natural health products, medical devices, cosmetics, and tobacco sectors achieve market access while adhering to authorization, licensing, and product safety regulations.

Sara’s adept at crafting strategies for product licensing, establishment certifications, and GMP/GPP programs. Her comprehensive compliance support includes drafting SOPs, evaluating product packaging and labeling, and overseeing advertising and marketing strategies with a keen eye on legal compliance and regulatory pre-clearance. Additionally, she provides insights into navigating privacy laws and information access, crucial for healthcare and related sectors.

Her contribution extends to crisis management and product recall advisories, ensuring businesses are prepared and responsive to potential product safety issues. Sara's depth of knowledge in the pharmaceutical, cannabis, and food and beverage industries is grounded in her active engagement with trade associations and regular dialogues with Health Canada, positioning her as a trusted advisor in her field.

Zborovski’s academic credentials include an LL.B. from the University of Toronto and a B.A. from McGill University, with legal admissions in Ontario and New York. Her recent legal endeavors include advising on significant acquisitions for JAMP Pharma Group, Swander Pace Capital, and pivotal transactions for Novo Nordisk A/S.

Her expertise is nationally recognized, with accolades from Chambers Canada, The Canadian Legal Lexpert Directory, and The Legal 500 Canada, highlighting her prominence in life sciences, regulatory compliance, and cannabis law.

Sara's prolific contributions to the legal landscape include authoring insightful publications and leading speaking engagements on emerging legal trends and regulatory updates, making her a pivotal figure in navigating the complexities of healthcare regulations and the dynamic legal framework surrounding cannabis and life sciences.